Kedrion Biopharma

We are thrilled to hear that Portugal will officially include Severe Combined Immunodeficiency (SCID) in its neonatal screening policies starting today. This significant advancement reflects our ongoing commitment to improving early detection and treatment of Immunodeficiencies. By advocating for this inclusion, we are one step closer to ensuring that affected infants receive timely interventions, ultimately enhancing their quality of life and health outcomes. We look forward to collaborating with healthcare providers and families to support this vital initiative and continue our mission in the fight against Immunodeficiencies side by side with patients’ associations and the medical community. A special thank you to all advocates who have worked tirelessly to make this happen. IPOPI - International Patient Organisation for Primary Immunodeficiencies, GPIP (Grupo Médico Português de Imunodeficiências Primárias), APDIP - Associação Portuguesa de Doentes com Imunodeficiências Primárias, Ricardo Pereira, Joana Silvério Marques. We are also grateful to Susana Viana for her support in the campaign. #SCID #NeonatalScreening #Immunodeficiencies #HealthcareInnovation #Portugal #EarlyDetection

🛡️ Protecting vulnerable populations beyond Rare Disease Day We are proud to announce the publication of a study on Aceruloplasminemia (ACP) in eBioMedicine, in collaboration with our partners Università di Pisa, Ospedale San Raffaele, Humanitas University, Humanitas Research Hospital. This research highlights our commitment to safeguarding the health of vulnerable populations affected by extremely rare diseases. ACP often goes undiagnosed, leaving patients without necessary care. This study enhances the understanding of the condition and improves prevalence estimates, emphasizing the critical need for early diagnosis and intervention. Andrea Caricasole #RareDiseases #PatientProtection #VulnerablePopulations #eBioMedicine

𝐍𝐎𝐓 𝐉𝐔𝐒𝐓 𝐓𝐎𝐃𝐀𝐘: 𝐋𝐞𝐭'𝐬 #𝐀𝐜𝐜𝐞𝐥𝐞𝐫𝐚𝐭𝐞𝐀𝐜𝐭𝐢𝐨𝐧 𝐄𝐯𝐞𝐫𝐲 𝐃𝐚𝐲! 💜🌍 Today, on 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐖𝐨𝐦𝐞𝐧'𝐬 𝐃𝐚𝐲, we celebrate progress-but we also recognize that true change happens every single day. Together, we stand for a world that is free of bias, stereotypes, and discrimination-a world that is 𝐝𝐢𝐯𝐞𝐫𝐬𝐞, 𝐞𝐪𝐮𝐢𝐭𝐚𝐛𝐥𝐞, 𝐚𝐧𝐝 𝐢𝐧𝐜𝐥𝐮𝐬𝐢𝐯𝐞, where 𝐞𝐯𝐞𝐫𝐲𝐨𝐧𝐞'𝐬 𝐯𝐚𝐥𝐮𝐞 𝐚𝐧𝐝 𝐬𝐭𝐫𝐞𝐧𝐠𝐭𝐡 𝐚𝐫𝐞 𝐫𝐞𝐜𝐨𝐠𝐧𝐢𝐳𝐞𝐝 𝐚𝐧𝐝 𝐜𝐞𝐥𝐞𝐛𝐫𝐚𝐭𝐞𝐝. At Kedrion, we are proud to support #IWD2025 and commit to 𝐚𝐜𝐜𝐞𝐥𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐚𝐜𝐭𝐢𝐨𝐧 beyond just one day. Our incoming Sustainability Report will highlight our journey, with 𝟑𝟔% 𝐨𝐟 𝐰𝐨𝐦𝐞𝐧 𝐢𝐧 𝐥𝐞𝐚𝐝𝐞𝐫𝐬𝐡𝐢𝐩 𝐚𝐧𝐝 𝟓𝟏% 𝐟𝐞𝐦𝐚𝐥𝐞 𝐫𝐞𝐩𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧-but we know there's more to do. Let's keep pushing forward-𝐧𝐨𝐭 𝐣𝐮𝐬𝐭 𝐭𝐨𝐝𝐚𝐲, 𝐛𝐮𝐭 𝐞𝐯𝐞𝐫𝐲 𝐝𝐚𝐲! 💜 #AccelerateAction #IWD2025 #GenderEquality #DEI #NotJustToday #SustainableImpact

Meet Ariel, 25. She grew up assuming she’d never be able to go to college or live independently. Her story marks the launch of Rare but Real: our new way to tell patient stories. They’re not about triumph over adversity, but hard-won normality. About patients living life on their own terms, just like anyone else. And just like Rare Disease Day, they’re about raising awareness and generating change. P.S. Ariel’s a neuroscientist now. #rarebutreal #rarediseaseday2025

📢 🎤 𝐄𝐧𝐠𝐚𝐠𝐢𝐧𝐠 𝐰𝐢𝐭𝐡 𝐏𝐏𝐓𝐀: 𝐔𝐧𝐢𝐭𝐢𝐧𝐠 𝐁𝐞𝐡𝐢𝐧𝐝 𝐚 𝐒𝐡𝐚𝐫𝐞𝐝 𝐌𝐢𝐬𝐬𝐢𝐨𝐧 𝐨𝐟 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐀𝐜𝐜𝐞𝐬𝐬 𝐚𝐧𝐝 𝐀𝐯𝐚𝐢𝐥𝐚𝐛𝐢𝐥𝐢𝐭𝐲 𝐢𝐧 𝐄𝐮𝐫𝐨𝐩𝐞   Recently during our internal meeting, we had the privilege of interviewing Marilena Vrana (Senior Director, Lead for Public Affairs Europe, PPTA). In this video, Marilena shares key challenges and opportunities shaping the plasma sector in Europe.   Her insightful remarks reinforce the importance of ongoing collaboration between industry and PPTA to protect and promote patient access, availability, and awareness of lifesaving plasma-derived therapies.   A special thank you to Marilena for sharing her expertise and fostering this crucial dialogue. These conversations are essential to advancing our shared mission.   #PlasmaIndustry #PPTA #Collaboration #PatientCare #SafetyFirst PPTA Europe

We thank the JAGGAER Team for their valuable support and invite everyone to learn more about our journey in procurement within the biopharma sector.

The Affianco project was born from the desire to listen, understand, and offer concrete support to those who too often feel alone. We immediately felt close to AIP's goal because Kedrion, like this association, is made up of people who put their hearts into their work, aware that research and innovation are fundamental, but that empathy and human connection are just as important. For these reasons, we are so proud of Affianco's victory for “Best Communication Campaign – nonprofessionals” at the OMaR Award, a prize that recognizes communication on rare diseases and rare tumors. Yesterday evening in Rome, we were deeply moved and excited to collect the award together. Given the proximity to #RareDiseaseDay, today we celebrate not only this achievement but, above all, the strength of a community that never gives up. This award is for all of them. For patients, their families, volunteers, plasma donors and the healthcare professionals who support these communities so closely every day. But it is also for all those who believe in a future where no one is left behind. Ilaria Ciancaleoni Bartoli Osservatorio Malattie Rare Silvia Casati

🌟 𝐋𝐚𝐬𝐭 𝐰𝐞𝐞𝐤 𝐰𝐚𝐬 𝐯𝐞𝐫𝐲 𝐬𝐢𝐠𝐧𝐢𝐟𝐢𝐜𝐚𝐧𝐭 𝐟𝐨𝐫 𝐊𝐞𝐝𝐫𝐢𝐨𝐧! 🌟   From February 10-13, Kedrion’s delegation (Duccio Manetti, PhD, Ferdinando Borgese, and Aleksandar Marinković) visited Tashkent, the capital of Uzbekistan, to meet with government officials, physicians, and patient associations to discuss the current status and future prospects of plasma-derived therapies in the country.   We were honored to meet with the Minister of Health, Khudayarov Asilbek Anvarovich; the Minister of Industry, Kudratov Laziz Shavkatovich; and the Director of the Agency for the Development of the Pharmaceutical Industry, Abdulla Azizov .   These meetings paved the way for future agreements and collaborations aimed at addressing the therapeutic needs of Uzbek patients with rare and ultra-rare diseases.   We also visited the Hematology Center of the Pediatric Oncology Hospital. Engaging with physicians and patients always provides a powerful reminder of the importance of our ongoing mission to expand patient access to plasma-derived therapies worldwide.   Thank you to the Italian Embassy in Tashkent for their invaluable assistance.   #Collaboration #PatientCare

We are proud to partner with Pharmacosmos on #WorldAnemiaAwarenessDay. Our commitment to supporting patients in Italy affected by iron deficiency anemia is stronger than ever. Let's join together to raise awareness and improve the quality of life for those in need.

Science isn't just about equations and experiments; it's about courage. It takes courage to challenge established ideas, to persevere through setbacks, and to stand tall in a world that sometimes whispers you shouldn't be here. Nisha Jain, our VP, Global Clinical Development, is here to tell you why #courage is the secret ingredient for a scientist. Spoiler alert: it's the courage to ask "why?" when others accept "how." It's the courage to raise your hand, share your ideas, and understand that your voice matters. Don’t allow anyone to dim your spark or tell you what you can’t achieve. Embrace the challenge, ignite your passion, and let your curiosity lead the way. #InternationalDayofWomenandGirlsinScience